Release of a paramagnetic magnetic resonance imaging agent from liposomes triggered by low intensity non-focused ultrasound

Journal of Medical Imaging and Health Informatics

Volumn 3, Issue 3, 2013, Pages 356-366

  Giustetto, Pierangela ^a   Castelli, Daniela Delli ^a   Boffa, Cinzia ^a   Rizzitelli, Silvia ^a   Durando, Davide ^a   Cutrin, Juan Carlos ^a,b   Aime, Silvio ^a   Terreno, Enzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Cardiological Investigation Institute   (Argentina)

Author keywords

Image Guided Drug Release; Liposomes; MRI; Non Focused Ultrasound; Theranostics; Ultrasound

Indexed keywords

1 PALMITOYL 2 OLEYL SN GLYCERO 3 PHOSPHOCOLINE; 1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOGLYCEROL; 1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOCHOLINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; GADOTERIDOL; LIPOSOME; MACROGOL 2000; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; IN VIVO CULTURE; LOW INTENSITY NON FOCUSED ULTRASOUND; MELANOMA B16; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHYSICAL CHEMISTRY; THERAPY; ULTRASOUND;

EID: 84881233168     PISSN: 21567018     EISSN: 21567026     Source Type: Journal    
DOI: 10.1166/jmihi.2013.1183     Document Type: Article

References (51)

1. V. P. Torchilin, Recent advances with liposomes as pharmaceutical carriers. Nature reviews. Drug Discovery 4, 1 (2005).
2. J. Wang, M. Sui, and W. Fan, Nanoparticles for tumor targeted therapies and their pharmacokinetics. Current Drug Metabolism 11, 129 (2010).
3. X. Guo and F. C. Szoka, Jr, Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Acc. Chem. Res. 36, 1 (2003).
4. A. H. Negussie, P. S. Yarmolenko, A. Partanen, A. Ranjan, G. Jacobs, D. Woods, H. Bryant, D. Thomasson, M. W. Dewhirst, B. J. Wood, and M. R. Dreher, Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. International Journal of Hyperthermia: The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 27, 1 (2011).
5. M. de Smet, E. Heijman, S. Langereis, N. M. Hijnen, and H. Grüll, Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: An in vivo proof-of-concept study. J. Controlled Release 150, 102 (2011).
6. C. Oerlemans, F. Nijsen, M. van Amersfoort, L. van Bloois, E. Heijman, P. Luijten, W. Mali, and G. Storm, A novel approach to identify non-palpable breast lesions combining fluorescent liposomes and magnetic resonanceguided high intensity focused ultrasound-triggered release. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e. V. 77, 458 (2011).
7. F. Yang, T. Wong, M. Teng, R. Liu, M. Lu, H. Liang, and M. Wei, Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. Journal of Controlled Release: Official Journal of the Controlled Release Society 160, 652 (2012).
8. H.-Y. Lin and J. L. Thomas, PEG-Lipids and Oligo(ethylene glycol) Surfactants Enhance the Ultrasonic Permeabilizability of Liposomes (2003).
9. H.-Y. Lin and J. L. Thomas, Factors affecting responsivity of unilamellar liposomes to 20 khz ultrasound. Langmuir 20, 6100 (2004).
10. A. Schroeder, J. Kost, and Y. Barenholz, Ultrasound, liposomes, and drug delivery: Principles for using ultrasound to control the release of drugs from liposomes. Chem. Phys. Lipids 162, 1 (2009).
11. Z. H. Ren, J. Y. Wang, C. L. Zou, Y. Q. Guan, and Y. A. Zhang, Labeling of cynomolgus monkey bone marrow-derived mesenchymal stem cells for cell tracking by multimodality imaging. Science China Life Sciences 54, 981 (2011).
12. J. R. Lattin, W. G. Pitt, D. M. Belnap, and G. A. Husseini, Ultrasoundinduced calcein release from eliposomes, Ultrasound in Medicine and Biology 38, 2163 (2012).
13. E. F. Small, M. C. Willy, P. A. Lewin, and S. P. Wrenn, Ultrasound-induced transport across lipid bilayers: Influence of phase behavior, Colloids and Surfaces A: Physicochemical and Engineering Aspects 390, 1 (2011).
14. A. Schroeder, R. Honen, K. Turjeman, A. Gabizon, J. Kost, and Y. Barenholz, Ultrasound triggered release of cisplatin from liposomes in murine tumors. J. Controlled Release 137, 63 (2009).
15. W. G. Pitt, G. A. Husseini, B. L. Roeder, D. J. Dickinson, D. R. Warden, J. M. Hartley, and P. W. Jones, Preliminary results of combining low frequency low intensity ultrasound and liposomal drug delivery to treat tumors in rats. Journal of nanoscience and nanotechnology 11, 1866 (2011).
16. A. Schroeder, Y. Avnir, S. Weisman, Y. Najajreh, A. Gabizon, Y. Talmon, J. Kost, and Y. Barenholz, Controlling liposomal drug release with low frequency ultrasound: Mechanism and feasibility. Langmuir 23, 4019 (2007).
17. M. Afadzi, C. L. Davies, Y. H. Hansen, T. Johansen, Ø. K. Standal, R. Hansen, S. E. Måsøy, E. A. Nilssen, and B. Angelsen, Effect of ultrasound parameters on the release of liposomal calcein. Ultrasound in Medicine and Biology (2012).
18. P. Prabhu and V. Patravale, The upcoming field of theranostic nanomedicine: An overview. Journal of Biomedical Nanotechnology 8, 859 (2012).
19. S. Erdogan, Liposomal nanocarriers for tumor imaging. Journal of Biomedical Nanotechnology 5, 141 (2009).
20. X. Chen, S. S. Gambhir, and J. Cheon, Theranostic nanomedicine. Acc. Chem. Res. 44, 841 (2011).
21. E. Terreno, F. Uggeri, and S. Aime, Image guided therapy: The advent of theranostic agents. J. Controlled Release 161, 328 (2012).
22. E. Terreno, D. D. Castelli, A. Viale, and S. Aime, Challenges for molecular magnetic resonance imaging. Chem. Rev. 110, 3019 (2010).
23. W. Mulder, B. NMR, G. Strijkers, G. van Tilborg, A. Griffioen, A. Laboratory, K. Nicolay, W. J. Mulder, G. J. Strijkers, G. A. van Tilborg, and A. W. Griffioen, Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR in Biomedicine 19, 142 (2006).
24. M. A. Oghabian and N. M. Farahbakhsh, Potential use of nanoparticle based contrast agents in mri: a molecular imaging perspective. Journal of Biomedical Nanotechnology 6, 203 (2010).
25. D. Delli Castelli, E. Gianolio, S. Geninatti Crich, E. Terreno, and S. Aime, Metal containing nanosized systems for MR-Molecular Imaging applications. Coord. Chem. Rev. 252, 2424 (2008).
26. H. Fattahi, S. Laurent, F. Liu, N. Arsalani, L. vander Elst, and R. N. Muller, Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics. Nanomedicine 6, 529 (2011).
27. S. Aime, D. D. Castelli, S. G. Crich, E. Gianolio, and E. Terreno, Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc. Chem. Res. 42, 822 (2009).
28. T. Y. Liu and T. C. Huang, A novel drug vehicle capable of ultrasound-triggered release with MRI functions. Acta Biomaterialia 7, 3927 (2011).
29. E. Terreno, A. Barge, L. Beltrami, G. Cravotto, D. Delli Castelli, F. Fedeli, B. Jebasingh, and S. Aime, Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents. Chem. Commun. 600 (2008).
30. J. Lasch, V. Weissig, and M. Brandl, Preparation of liposomes, in "Liposomes," edited by V. P. Torchilin and V. Weissig, Oxford University Press, Oxford, UK (2003).
31. D. M. Corsi, C. Platas-Iglesias, H. Bekkum, and J. A. Peters, Determination of paramagnetic lanthanide (III) concentrations from bulk magnetic susceptibility shifts in NMR spectra. Magn. Reson. Chem. 39, 723 (2001).
32. V. Zderic, S. Vaezy, R. W. Martin, and J. I. Clark, Ocular drug delivery using 20-kHz ultrasound. Ultrasound in Medicine and Biology 28, 823 (2002).
33. S. Datta, C. C. Coussios, L. E. McAdory, J. Tan, T. Porter, G. de Courten-Myers, and C. K. Holland, Correlation of cavitation with ultrasound enhancement of thrombolysis. Ultrasound in Medicine and Biology 32, 1257 (2006).
34. L. C. Phillips, A. L. Klibanov, B. R. Wamhoff, and J. A. Hossack, Localized ultrasound enhances delivery of rapamycin from microbubbles to prevent smooth muscle proliferation. J. Controlled Release 154, 42 (2011).
35. E. Terreno, A. Sanino, C. Carrera, D. D. Castelli, G. B. Giovenzana, A. Lombardi, R. Mazzon, L. Milone, M. Visigalli, and S. Aime, Determination of water permeability of paramagnetic liposomes of interest in MRI field. J. Inorg. Biochem. 102, 1112 (2008).
36. D. E. Discher and F. Ahmed, Polymersomes. Annu. Rev. Biomed. Eng. 8, 323 (2006).
37. T. J. Evjen, E. A. Nilssen, S. Rögnvaldsson, M. Brandl, and S. L. Fossheim, Distearoylphosphatidylethanolamine-based liposomes for ultrasoundmediated drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 75, 327 (2010).
38. E. Hagtvet, T. J. Evjen, D. R. Olsen, S. L. Fossheim, and E. A. Nilssen, Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice. Journal of Drug Targeting 19, 701 (2011).
39. T. J. Evjen, E. Hagtvet, E. A. Nilssen, M. Brandl, and S. L. Fossheim, Sonosensitive dioleoylphosphatidylethanolamine-containing liposomes with prolonged blood circulation time of doxorubicin. European Journal of Pharmaceutical Sciences 43, 318 (2011).
40. E. Terreno, C. Cabella, C. Carrera, D. Delli Castelli, R. Mazzon, S. Rollet, J. Stancanello, M. Visigalli, and S. Aime, From spherical to osmotically shrunken paramagnetic liposomes: An improved generation of lipocest mri agents with highly shifted water protons. Angewandte Chemie 119, 984 (2007).
41. X. Duan and Y. Li, Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small (2012).
42. E. Terreno, D. Delli Castelli, E. Violante, H. M. H. F. Sanders, N. A. Sommerdijk, and S. Aime, Osmotically shrunken lipocest agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer, Chem. Eur. J. 15, 1440 (2009).
43. L. Somaglino, G. Bouchoux, J. Mestas, and C. Lafon, Validation of an acoustic cavitation dose with hydroxyl radical production generated by inertial cavitation in pulsed mode: Application to in vitro drug release from liposomes. Ultrason. Sonochem. 18, 577 (2011).
44. H. Yima, S. G. Yangb, Y. S. Jeonc, I. S. Parkd, M. Kimb, D. H. Leeb, Y. H. Baeb, and K. Naa, The performance of gadolinium diethylene triamine pentaacetatepullulan hepatocyte-specific T1 contrast agent for MRI. 32, 5187 (2011).
45. D. Castelli, D. O. Chemistry, E. Terreno, C. Cabella, C. B. Imaging, L. Chaabane, S. Lanzardo, D.O. Sciences, L. Tei, M. Visigalli, S. Aime, E. Terreno, D. Delli Castelli, D. O. Chemistry, C. Cabella, L. Chaabane, C. B. Imaging, S. Lanzardo, L. Tei, D. O. Sciences, M. Visigalli, C. B. Imaging, S. Aime, D. O. Chemistry, and D. O. Chemistry, Evidence for macrophage mediated tumor uptake of paramagnetic/fluorescent liposomes. NMR in Biomedicine 22, 1084 (2009).
46. E. Y. K. Ng, W. K. Ng, and S. S. Chiam, Optimization of nanoparticle drug microcarrier on the pharmacokinetics of drug release: a preliminary study, J. Med. Syst. 32, 85 (2008).
47. M. Ferraretto, E. Torres, A. Maiocchi, B. J. Crielaard, T. Lammers, G. Storm, S. Aime, and E. Terreno, MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate. Eur. J. Pharm. Sci. 45, 436 (2012).
48. C. Kuhl, P. Mielcareck, S. Klaschik, C. Leutner, E. Wardelmann, J. Gieseke, and H. Schild, Dynamic breast mr imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions radiology. 211, 101 (1999).
49. A. H. Negussie, P. S. Yarmolenko, A. Partanen, A. Ranjan, G. Jacobs, D. Woods, H. Bryant, D. Thomasson, M. W. Dewhirst, B. J. Wood, and M. R. Dreher, Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. Int. J. Hyperthermia 27, 140 (2011).
50. O. M. Al-Bataineh, K. Lweesy, and L. Fraiwan, In-vivo evaluation of a noninvasive transdermal insulin delivery system utilizing ultrasound transducers. Journal of Medical Imaging and Health Informatics 3, 3267 (2011).
51. T. J. Evjen, E. A. Nilssen, S. Barnert, R. Schubert, M. Brandl, and S. L. Fossheim, Ultrasound-mediated destabilization and drug release from liposomes comprising dioleoylphosphatidylethanolamine. Eur. J. Pharm. Sci. 42, 380 (2011).